PharmChem Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999
Period Ending	Mar '04 Mar 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002	Dec '01 Dec 31, 2001	Dec '00 Dec 31, 2000	Dec '99 Dec 31, 1999
Revenue	25.73	26.46	30.09	36.57	39.39	44.49
Revenue Growth (YoY)	-11.12%	-12.07%	-17.72%	-7.18%	-11.45%	3.05%
Cost of Revenue	19.98	20.59	23.01	32.53	28.97	31.37
Gross Profit	5.74	5.86	7.07	4.04	10.43	13.11
Selling, General & Admin	7.28	7.44	7.74	11.83	9.71	10.03
Operating Expenses	7.28	7.44	7.86	12.13	9.63	10.36
Operating Income	-1.53	-1.58	-0.78	-8.1	0.8	2.75
Interest Expense	-0.42	-0.5	-0.65	-0.46	-0.28	-0.28
Interest & Investment Income	-	-	0.14	0	0.01	0.02
Other Non Operating Income (Expenses)	-0.02	-0.01	-0.07	0.02	0.03	0.02
EBT Excluding Unusual Items	-1.98	-2.08	-1.36	-8.53	0.56	2.51
Merger & Restructuring Charges	-	-	-	-1.03	-	-
Impairment of Goodwill	-0.73	-0.73	-	-	-	-
Other Unusual Items	0.67	0.67	-	-	-	-
Pretax Income	-2.04	-2.15	-1.36	-9.56	0.56	2.51
Income Tax Expense	-	-	-0.07	-0.09	0.26	-0.29
Earnings From Continuing Operations	-2.04	-2.15	-1.29	-9.48	0.29	2.8
Earnings From Discontinued Operations	-	-	4.64	1	1.07	-
Net Income	-2.04	-2.15	3.34	-8.48	1.36	2.8
Net Income to Common	-2.04	-2.15	3.34	-8.48	1.36	2.8
Net Income Growth	-	-	-	-	-51.39%	340.94%
Shares Outstanding (Basic)	6	6	6	6	6	6
Shares Outstanding (Diluted)	6	6	6	6	6	6
Shares Change (YoY)	-	-	0.03%	-3.59%	1.93%	-4.55%
EPS (Basic)	-0.35	-0.37	0.57	-1.45	0.23	0.48
EPS (Diluted)	-0.35	-0.37	0.57	-1.45	0.23	0.47
EPS Growth	-	-	-	-	-51.95%	370.00%
Free Cash Flow	-	-	-0.08	-8.88	0.21	0.43
Free Cash Flow Per Share	-	-	-0.01	-1.52	0.03	0.07
Gross Margin	22.32%	22.16%	23.51%	11.04%	26.46%	29.48%
Operating Margin	-5.96%	-5.96%	-2.60%	-22.15%	2.02%	6.19%
Profit Margin	-7.94%	-8.12%	11.11%	-23.18%	3.45%	6.29%
Free Cash Flow Margin	-	-	-0.26%	-24.29%	0.52%	0.97%
EBITDA	-	0.52	1.47	-6.07	2.75	4.81
EBITDA Margin	-	1.98%	4.88%	-16.60%	6.99%	10.81%
D&A For EBITDA	-	2.1	2.25	2.03	1.96	2.06
EBIT	-1.53	-1.58	-0.78	-8.1	0.8	2.75
EBIT Margin	-5.96%	-5.96%	-2.60%	-22.15%	2.02%	6.19%
Effective Tax Rate	-	-	-	-	47.31%	-

Updated May 14, 2004. Source: S&P Global Market Intelligence. Standard template. Financial Sources.